Glipizide
Product Images NDC 67296-2042

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 67296-2042). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Of Glipizide (Image 1)

Chemical structure of Glipizide, showing its molecular components including a pyridine ring and sulfonylurea moiety.*

FDA Label Image

1 (Image 2)

Label for GlipiZIDE Tablets, USP 5 mg, indicating the active ingredient glipizide. The label includes dosage strength, a quantity of 100 tablets, and is marked Rx only. It shows storage instructions and manufacturing details, including Teva Pharmaceuticals USA, Inc. as the labeler and production in India. The label also displays a barcode and serialization coding area.*

FDA Label Image

1 (Image 3)

Glipizide Tablets USP 10 mg label from Redpharm drug (manufactured by Watson Pharma Private Limited and Teva Pharmaceuticals USA). The label shows NDC 0591-0461-01, tablet strength of 10 mg, quantity of 100 tablets, and storage instructions. The label includes barcode and serialization coding area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.